Matthias Lohmann
Inventor
Stats
- 4 US patents issued
- 6 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 4 US Patents Issued
- 6 US Applications Filed
- 4 Total Citation Count
- Feb 20, 2018 Most Recent Filing
- Feb 21, 2014 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| JOSLIN DIABETES CENTER, INC. | 3
| 2014
|
| SANOFI | 2
4 | 2015
2016 |
Inventor Addresses
| Address | Duration |
|---|---|
| Frankfurt Am Main, DE | Jan 26, 17 - Feb 02, 17 |
| Frankfurt am Main, DE | Dec 24, 15 - Aug 27, 19 |
| Frankfurt, DE | Jan 07, 16 - Jan 07, 16 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 5 |
| C07D: | HETEROCYCLIC COMPOUNDS | 4 |
| C07K: | PEPTIDES | 2 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 10392366 | 2019 | Azetidine compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders | 1 |
| 2018/0237,419 | 2018 | AZETIDINE COMPOUNDS AS GRP119 MODULATORS FOR THE TREATMENT OF DIABETES, OBESITY, DYSLIPIDEMIA AND RELATED DISORDERS | 2 |
| 9908868 | 2018 | Isoindolinone compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders | 0 |
| 9896434 | 2018 | Substituted indanone compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders | 0 |
| 9763998 | 2017 | Serpins: methods of therapeutic β-cell regeneration and function | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.